Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.

Semina SE, Huggins RJ, Zhao H, Yanagihara K, Sheinin M, Macias V, Alani F, Feferman L, Kajdacsy-Balla AA, Tonetti DA, Hoskins KF, Greene GL, Frasor J, Coloff JL

Open source

DOI: 10.64898/2026.09.10.750719
Published: 2026 Sep 16
Container: bioRxiv : the preprint server for biology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.09.10.750719,
  title = {Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.},
  author = {Semina SE and Huggins RJ and Zhao H and Yanagihara K and Sheinin M and Macias V and Alani F and Feferman L and Kajdacsy-Balla AA and Tonetti DA and Hoskins KF and Greene GL and Frasor J and Coloff JL},
  year = {2026},
  journal = {bioRxiv : the preprint server for biology},
  doi = {10.64898/2026.09.10.750719},
  url = {https://doi.org/10.64898/2026.09.10.750719}
}

RIS

TY  - JOUR
TI  - Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.
AU  - Semina SE
AU  - Huggins RJ
AU  - Zhao H
AU  - Yanagihara K
AU  - Sheinin M
AU  - Macias V
AU  - Alani F
AU  - Feferman L
AU  - Kajdacsy-Balla AA
AU  - Tonetti DA
AU  - Hoskins KF
AU  - Greene GL
AU  - Frasor J
AU  - Coloff JL
PY  - 2026
JO  - bioRxiv : the preprint server for biology
DO  - 10.64898/2026.09.10.750719
UR  - https://doi.org/10.64898/2026.09.10.750719
ER  -

APA

SE, S., RJ, H., H, Z., K, Y., M, S., V, M., F, A., L, F., AA, K., DA, T., KF, H., GL, G., J, F., & JL, C. (2026). Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.09.10.750719

Source records

pubmed · retrieved 2026-09-25T08:19:06.171Z